Welcome to LookChem.com Sign In|Join Free

CAS

  • or

82846-18-2

Post Buying Request

82846-18-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

82846-18-2 Usage

Chemical Properties

White to light yellow crystal powder

Check Digit Verification of cas no

The CAS Registry Mumber 82846-18-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,8,4 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 82846-18:
(7*8)+(6*2)+(5*8)+(4*4)+(3*6)+(2*1)+(1*8)=152
152 % 10 = 2
So 82846-18-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H7FO3/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4H,1H3,(H,10,11)

82846-18-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L19673)  4-Fluoro-3-methoxybenzoic acid, 95%   

  • 82846-18-2

  • 1g

  • 1005.0CNY

  • Detail
  • Alfa Aesar

  • (L19673)  4-Fluoro-3-methoxybenzoic acid, 95%   

  • 82846-18-2

  • 5g

  • 3580.0CNY

  • Detail

82846-18-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Fluoro-3-Methoxybenzoic Acid

1.2 Other means of identification

Product number -
Other names 4-FLUORO-3-METHOXYBENZOIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:82846-18-2 SDS

82846-18-2Relevant articles and documents

HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK

-

Paragraph 0175, (2014/05/24)

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

Pyrimido compounds having antiproliferative activity

-

Page/Page column 42, (2010/02/08)

Disclosed are novel pyrimido compounds that are selective inhibitors of both KDR and FGFR kinases. These compounds and their pharmaceutically acceptable salts are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds and methods of treating cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 82846-18-2